1471 related articles for article (PubMed ID: 15805295)
1. Up-regulation of inhibitory natural killer receptors CD94/NKG2A with suppressed intracellular perforin expression of tumor-infiltrating CD8+ T lymphocytes in human cervical carcinoma.
Sheu BC; Chiou SH; Lin HH; Chow SN; Huang SC; Ho HN; Hsu SM
Cancer Res; 2005 Apr; 65(7):2921-9. PubMed ID: 15805295
[TBL] [Abstract][Full Text] [Related]
2. Prostaglandin E2 induces the expression of functional inhibitory CD94/NKG2A receptors in human CD8+ T lymphocytes by a cAMP-dependent protein kinase A type I pathway.
Zeddou M; Greimers R; de Valensart N; Nayjib B; Tasken K; Boniver J; Moutschen M; Rahmouni S
Biochem Pharmacol; 2005 Sep; 70(5):714-24. PubMed ID: 15978547
[TBL] [Abstract][Full Text] [Related]
3. The role of TCR stimulation and TGF-beta in controlling the expression of CD94/NKG2A receptors on CD8 T cells.
Gunturi A; Berg RE; Crossley E; Murray S; Forman J
Eur J Immunol; 2005 Mar; 35(3):766-75. PubMed ID: 15714583
[TBL] [Abstract][Full Text] [Related]
4. HLA class I-specific inhibitory receptors in human T lymphocytes: interleukin 15-induced expression of CD94/NKG2A in superantigen- or alloantigen-activated CD8+ T cells.
Mingari MC; Ponte M; Bertone S; Schiavetti F; Vitale C; Bellomo R; Moretta A; Moretta L
Proc Natl Acad Sci U S A; 1998 Feb; 95(3):1172-7. PubMed ID: 9448304
[TBL] [Abstract][Full Text] [Related]
5. Activating CD94:NKG2C and inhibitory CD94:NKG2A receptors are expressed by distinct subsets of committed CD8+ TCR alphabeta lymphocytes.
Arlettaz L; Villard J; de Rham C; Degermann S; Chapuis B; Huard B; Roosnek E
Eur J Immunol; 2004 Dec; 34(12):3456-64. PubMed ID: 15517612
[TBL] [Abstract][Full Text] [Related]
6. Interleukin-15-induced maturation of human natural killer cells from early thymic precursors: selective expression of CD94/NKG2-A as the only HLA class I-specific inhibitory receptor.
Mingari MC; Vitale C; Cantoni C; Bellomo R; Ponte M; Schiavetti F; Bertone S; Moretta A; Moretta L
Eur J Immunol; 1997 Jun; 27(6):1374-80. PubMed ID: 9209487
[TBL] [Abstract][Full Text] [Related]
7. Altered CD94/NKG2A and perforin expression reduce the cytotoxic activity in malignant pleural effusions.
Pace E; Di Sano C; Ferraro M; Tipa A; Olivieri D; Spatafora M; Santagata R; Bellia V; Gjomarkaj M
Eur J Cancer; 2011 Jan; 47(2):296-304. PubMed ID: 20932742
[TBL] [Abstract][Full Text] [Related]
8. Differential expression of natural killer cell receptors (CD94/NKG2A) on T cells by the stimulation of G-CSF-mobilized peripheral blood mononuclear cells with anti-CD3 monoclonal antibody and cytokines: a study in stem cell donors.
Tanaka J; Toubai T; Miura Y; Tsutsumi Y; Kato N; Umehara S; Toyoshima N; Ohta S; Asaka M; Imamura M
Transplant Proc; 2004 Oct; 36(8):2511-2. PubMed ID: 15561299
[TBL] [Abstract][Full Text] [Related]
9. Differential effects of interleukin-12 and interleukin-15 on expansion of NK cell receptor-expressing CD8+ T cells.
Sugita J; Tanaka J; Yasumoto A; Shiratori S; Wakasa K; Kikuchi M; Shigematsu A; Kondo T; Asaka M; Imamura M
Ann Hematol; 2010 Feb; 89(2):115-20. PubMed ID: 19578849
[TBL] [Abstract][Full Text] [Related]
10. Triggering of effector functions on a CD8+ T cell clone upon the aggregation of an activatory CD94/kp39 heterodimer.
Bellón T; Heredia AB; Llano M; Minguela A; Rodriguez A; López-Botet M; Aparicio P
J Immunol; 1999 Apr; 162(7):3996-4002. PubMed ID: 10201920
[TBL] [Abstract][Full Text] [Related]
11. Differing phenotypes between intraepithelial and stromal lymphocytes in early-stage tongue cancer.
Katou F; Ohtani H; Watanabe Y; Nakayama T; Yoshie O; Hashimoto K
Cancer Res; 2007 Dec; 67(23):11195-201. PubMed ID: 18056444
[TBL] [Abstract][Full Text] [Related]
12. Expansion of natural killer cell receptor (CD94/NKG2A)-expressing cytolytic CD8 T cells and CD4+CD25+ regulatory T cells from the same cord blood unit.
Tanaka J; Sugita J; Kato N; Toubai T; Ibata M; Shono Y; Ota S; Kondo T; Kobayashi T; Kobayashi M; Asaka M; Imamura M
Exp Hematol; 2007 Oct; 35(10):1562-6. PubMed ID: 17681668
[TBL] [Abstract][Full Text] [Related]
13. Expression of CD94 and NKG2 molecules on human CD4(+) T cells in response to CD3-mediated stimulation.
Romero P; Ortega C; Palma A; Molina IJ; Peña J; Santamaría M
J Leukoc Biol; 2001 Aug; 70(2):219-24. PubMed ID: 11493613
[TBL] [Abstract][Full Text] [Related]
14. Increased expression of the natural killer cell inhibitory receptor CD94/NKG2A and CD158b on circulating and lesional T cells in patients with chronic plaque psoriasis.
Liao YH; Jee SH; Sheu BC; Huang YL; Tseng MP; Hsu SM; Tsai TF
Br J Dermatol; 2006 Aug; 155(2):318-24. PubMed ID: 16882169
[TBL] [Abstract][Full Text] [Related]
15. Expression patterns of lectin-like natural killer receptors, inhibitory CD94/NKG2A, and activating CD94/NKG2C on decidual CD56bright natural killer cells differ from those on peripheral CD56dim natural killer cells.
Kusumi M; Yamashita T; Fujii T; Nagamatsu T; Kozuma S; Taketani Y
J Reprod Immunol; 2006 Jun; 70(1-2):33-42. PubMed ID: 16488482
[TBL] [Abstract][Full Text] [Related]
16. The CD94/NKG2C killer lectin-like receptor constitutes an alternative activation pathway for a subset of CD8+ T cells.
Gumá M; Busch LK; Salazar-Fontana LI; Bellosillo B; Morte C; García P; López-Botet M
Eur J Immunol; 2005 Jul; 35(7):2071-80. PubMed ID: 15940674
[TBL] [Abstract][Full Text] [Related]
17. CD94/NKG2 inhibitory receptor complex modulates both anti-viral and anti-tumoral responses of polyclonal phosphoantigen-reactive V gamma 9V delta 2 T lymphocytes.
Poccia F; Cipriani B; Vendetti S; Colizzi V; Poquet Y; Battistini L; López-Botet M; Fournié JJ; Gougeon ML
J Immunol; 1997 Dec; 159(12):6009-17. PubMed ID: 9550399
[TBL] [Abstract][Full Text] [Related]
18. HLA-G recognition by human natural killer cells. Involvement of CD94 both as inhibitory and as activating receptor complex.
Pende D; Sivori S; Accame L; Pareti L; Falco M; Geraghty D; Le Bouteiller P; Moretta L; Moretta A
Eur J Immunol; 1997 Aug; 27(8):1875-80. PubMed ID: 9295021
[TBL] [Abstract][Full Text] [Related]
19. CD94-NKG2A receptors regulate antiviral CD8(+) T cell responses.
Moser JM; Gibbs J; Jensen PE; Lukacher AE
Nat Immunol; 2002 Feb; 3(2):189-95. PubMed ID: 11812997
[TBL] [Abstract][Full Text] [Related]
20. HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C.
Braud VM; Allan DS; O'Callaghan CA; Söderström K; D'Andrea A; Ogg GS; Lazetic S; Young NT; Bell JI; Phillips JH; Lanier LL; McMichael AJ
Nature; 1998 Feb; 391(6669):795-9. PubMed ID: 9486650
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]